# Clopidogrel Bioequivalence Study in Healthy Subjects

> **NCT02185534** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 144 (actual)

## Conditions studied

- Bioequivalence, AUC, Cmax, Pharmacokinetics

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02185534
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2016-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02185534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02185534, "Clopidogrel Bioequivalence Study in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02185534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*